|
Name |
ustusaustin A
|
Molecular Formula | C33H32O12 | |
IUPAC Name* |
(8-acetyloxy-2,2',2',9,13-pentamethyl-6-methylidene-6',10,12,15-tetraoxospiro[11,14,16-trioxapentacyclo[7.4.3.17,13.01,10.02,7]heptadecane-5,3'-pyran]-3-yl)benzoate
|
|
SMILES |
C=C1C2(C=CC(=O)OC2(C)C)CC(OC(=O)c2ccccc2)C2(C)C13OC14C(=O)OC(C)(C(=O)C12C(=O)OC4C)C3OC(C)=O
|
|
InChI |
InChI=1S/C33H32O12/c1-16-30(14-13-21(35)43-27(30,4)5)15-20(42-22(36)19-11-9-8-10-12-19)29(7)31-23(37)28(6)24(41-18(3)34)32(16,29)45-33(31,26(39)44-28)17(2)40-25(31)38/h8-14,17,20,24H,1,15H2,2-7H3/t17-,20-,24-,28+,29-,30+,31+,32+,33-/m0/s1
|
|
InChIKey |
DGWWXOOMSZIHEU-IKZGURBHSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 620.61 | ALogp: | 2.3 |
HBD: | 0 | HBA: | 12 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 157.8 | Aromatic Rings: | 7 |
Heavy Atoms: | 45 | QED Weighted: | 0.211 |
Caco-2 Permeability: | -5.234 | MDCK Permeability: | 0.00002750 |
Pgp-inhibitor: | 0.999 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.388 | 20% Bioavailability (F20%): | 0.999 |
30% Bioavailability (F30%): | 0.98 |
Blood-Brain-Barrier Penetration (BBB): | 0.324 | Plasma Protein Binding (PPB): | 75.65% |
Volume Distribution (VD): | 1.512 | Fu: | 20.01% |
CYP1A2-inhibitor: | 0.004 | CYP1A2-substrate: | 0.916 |
CYP2C19-inhibitor: | 0.194 | CYP2C19-substrate: | 0.788 |
CYP2C9-inhibitor: | 0.358 | CYP2C9-substrate: | 0.029 |
CYP2D6-inhibitor: | 0.02 | CYP2D6-substrate: | 0.031 |
CYP3A4-inhibitor: | 0.871 | CYP3A4-substrate: | 0.935 |
Clearance (CL): | 3.454 | Half-life (T1/2): | 0.008 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.269 |
Drug-inuced Liver Injury (DILI): | 0.975 | AMES Toxicity: | 0.965 |
Rat Oral Acute Toxicity: | 0.986 | Maximum Recommended Daily Dose: | 0.15 |
Skin Sensitization: | 0.018 | Carcinogencity: | 0.959 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.456 |
Respiratory Toxicity: | 0.523 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003179 | 0.714 | D06CWH | 0.285 | ||||
ENC003159 | 0.714 | D0O5WP | 0.280 | ||||
ENC005316 | 0.714 | D0C4RB | 0.279 | ||||
ENC006041 | 0.674 | D02HSB | 0.278 | ||||
ENC005315 | 0.642 | D04XPW | 0.235 | ||||
ENC003309 | 0.591 | D00OAY | 0.234 | ||||
ENC003776 | 0.551 | D0OG8A | 0.233 | ||||
ENC004311 | 0.544 | D03ZZK | 0.227 | ||||
ENC002849 | 0.489 | D0W7RJ | 0.226 | ||||
ENC002577 | 0.466 | D04ZAH | 0.222 |